152105-59-4

Upstream product

• 1481-92-1 2-(3-hydroxypropyl)phenol 
• 100-39-0 benzyl bromide 
• 51496-94-7 1-allyl-2-(benzyloxy)benzene 
• 280-64-8 9-bora-bicyclo[3.3.1]nonane 
• 79678-37-8 methyl 3-(benzyloxy)benzoate 
• 91-64-5 coumarin 

Downstream Products

• 1380169-65-2 C₁₇H₂₃N₃O₂ 
• 1380169-76-5 2-(3-propyl-TBD)-phenol 
• 1380169-72-1 2-(3-propyl-TBD)-benzyloxybenzene 
• 1380169-75-4 2-(3-chloropropyl)-benzyloxybenzene 
• 165803-68-9 3-[2-(benzyloxy)phenyl]propyl methanesulfonate 
• 209120-22-9 [(E)-4-(2-Benzyloxy-phenyl)-1-fluoro-but-1-enyl]-phosphonic acid diethyl ester 
• 209120-24-1 [(E)-1-Fluoro-4-(2-hydroxy-phenyl)-but-1-enyl]-phosphonic acid diethyl ester 
• 209120-23-0 [1-Fluoro-4-(2-hydroxy-phenyl)-butyl]-phosphonic acid diethyl ester 
• 75677-03-1 3-(2-benzyloxy-phenyl)-propionaldehyde 

Relevant academic research and scientific papers

SYNTHETIC METHODS

New strategies for the synthesis of salicylaldehyde derivatives having utility production of catalytic metal complexes.

Application of phenolate ion mediated intramolecular epoxide ring opening in the enantioselective synthesis of functionalized 2,3-dihydrobenzofurans and 1-benzopyrans

The enantioselective synthesis of 2-isopropenyl-2,3-dihydrobenzofurans, 4-(2,3-dihydrobenzofuran-2-yl)-2-methylbut-3-en-2-ols, 2-hydroxymethyl chromans, and 4-chroman-2-yl-2-methylbut-3-en-2-ols has been achieved using Sharpless asymmetric epoxidation-der

β-Hydroxy-α-tosyloxy esters as chiral building blocks for the enantioselective synthesis of benzo-annulated oxa-heterocycles: scope and limitations

The enantioselective synthesis of benzo-annulated oxa-heterocycles 2,3-dihydrobenzofuran and 1-benzopyran derivatives is described using β-hydroxy-α-tosyloxy esters as chiral building blocks, which are easily accessible through the regioselective α-tosyla

Synthesis of arylalkylmonofluorophosphonates as myo-inositol monophosphatase ligands

Arylalkylmonofluorophosphonates were prepared by condensation of arylalkylaldehydes with the lithium salt of diethyl 1-fluore-1- (trimethylsilyl)-methylphosphonate. Reduction and hydrolysis sequences gave the final products. These compounds do not inhibit

Pharmacologically active 4-[2-hydroxy-4-(substituted)phenyl]naphthalen-2(1H)-ones and 2-ols, derivatives thereof and intermediates therefor

Compounds having the formula STR1 wherein STR2 R1 is hydrogen, benzyl or alkanoyl, X is C2-4 alkylene; and Z-W is alkyl, phenylalkyl or pyridylalkyl which can have an oxygen atom as part of the alkyl chain and their use as CNS agents, antidiarrheals and antiemetics. Processes for their preparation and intermediates therefor are described.